CSL Limited (ASX: CSL): What’s Quietly Building Behind These Half-Year Numbers?
CSL has released its half-year FY25 results, showing growth across its global platform and solid progress in key therapy areas. While the headline numbers are steady, multiple segments are shifting in ways that could shape the months ahead.
• Revenue rose 5 percent to US$8.48 billion
• Net profit after tax increased 6 percent to US$2.01 billion
• Immunoglobulin sales grew 15 percent across global markets
CSL Behring remains the core engine, supported by strong demand for PRIVIGEN, HIZENTRA and albumin. Plasma collections are increasing, while HEMGENIX continues its rollout into new markets. Network efficiency is improving, with collection costs gradually trending lower.
• Full-year NPATA guidance reaffirmed at 10 to 13 percent growth
• Vifor posted stable growth in nephrology and iron therapies
• Seqirus moderated due to softer US flu immunisation rates
The company continues to scale its global capabilities, with pipeline expansion and product launches tracking as planned. Regional performance remains balanced, with strength across North America, Europe and Asia.
Operations are advancing. Portfolio performance is steady. Execution remains tight.
While the market focus may shift between divisions, the internal rhythm of CSL’s business is beginning to align. Immunotherapies, gene therapy adoption and platform expansion are all in motion.
The setup is clear. What unfolds from here will depend on how these movements come together in the second half.
Web Travel Group (ASX: WEB): Is This the Next Global Travel Engine in the Making?
Fresh off its demerger from B2C operations, Web Travel Group is putting all its weight behind one thing — accelerating WebBeds as a pure-play B2B platform. And signs of that shift are already taking shape.
• Bookings climbed 20 percent to 8.4 million
• Total transaction value reached $4.9 billion, up 22 percent
• Platform now showing the fastest TTV growth among global travel peers
The first half brought softer margins, but that trend reversed in the second. Revenue stabilised at $328.4 million, with EBITDA at $120.6 million — reflecting strategic investment in contracting, tech and talent across key markets.
Asia Pacific, the Americas and Europe are all growing at double-digit rates.
The company has completed a $150 million buyback, absorbing nearly all potential dilution from its transition phase. It now holds $363.6 million in cash and is actively deploying it to scale operations and boost competitiveness in core regions.
• Booking value per transaction rose 2 percent
• Contracted hotel supply grew 7 percent year on year
• FY26 trading already pacing ahead of market-wide growth
The setup is there — a focused model, a high-growth platform and rising volumes across regions.
Web Travel Group is not chasing scale. It is building it — with a clear runway to its $10 billion TTV target by FY30. What comes next could reshape its standing in the global travel ecosystem.
(Source: Company Announcements)
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
